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Abstract: A new tool for precise structural modification of ion channel proteins - the in vivo 
nonsense suppression technique for incorporating unnatural amino acids - has been developed. 
This new tool allows the kind of systematic structure-function correlation studies that are 
commonly employed in physical organic chemistry to be applied to the important proteins of 
molecular neurobiology. In particular, the method has been applied to the nicotinic acetylcholine 
receptor, The differing roles of the numerous aromatic amino acids present at the agonist binding 
site can be distinguished. In addition, high precision studies of the ion channel region have 
produced new insights into the channel gating mechanism. 
INTRODUCTION 
Developing a chemical-scale understanding of the structures and mechanisms of action of the molecules of 
memory, thought, emotion, and sensory perception - physical organic chemistry on the brain - constitutes 
one of the greatest challenges of modem science. A serious impediment to such efforts is that these 
molecules are, for the most part, integral membrane proteins of the sort that are not amenable to high 
resolution structural evaluation by NMR or x-ray crystallography.( 1) Given this, we believe chemical 
methods - structure activity studies of the sort that have been the workhorse of physical organic chemistry 
since its beginning - have the best chance of producing new insights into these remarkable molecules. 
Our approach focuses four of the most powerful methods of modern science on this challenging 
problem. These are: 
chemical synthesis 
molecular biology 
electrophysiology 
computer modeling 
contributions to molecular neurobiology. 
With this array of tools, we believe physical organic chemists are in a position make significant 
THE /N V/VO NONSENSE SUPPRESSION TECHNIQUE 
The key to our approach is a new methodology developed jointly with Caltech Professor of Biology Henry 
Lester(2,3,4). It involves four steps (Figure 1): 
Site directed mutagenesis, incorporating a STOP (nonsense) codon (TAG) at the site where structural 
modification will occur. 
Chemical synthesis of an unnatural amino acid, and enzymatic ligation to a specially designed tRNA 
Injection of the aminoacyl tRNA and the mutant mRNA into aXenopus oocyte, which will synthesize 
the protein with the desired unnatural amino acid incorporated at the mutagenesis site, assemble a 
multisubunit system, and incorporate the protein into the surface membrane of the cell 
Evaluation of the resultant protein with electrophysiological methods 
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Fig. 1 Schematic of the in vivo nonsense suppression methodology. 
This will be recognized as the in vivo implementation of the in vitro methodology for unnatural amino 
acid incorporation developed by Schultz(5). Hopefully, it will also be appreciated that a living cell adds 
significant complications. The key development in this approach is a new tRNA - termed THG73 - that is 
especially efficient at delivering an unnatural amino acid and, more importantly, is highly resistant to 
reacylation with natural amino acids by the endogenous aminoacyl tRNA synthetases of the oocyte. Details 
of the approach have been presented elsewhere(3). We note here only that the method appears to be fairly 
general. We have incorporated over 40 different amino acids (both natural and unnatural) at 25 different 
sites in 10 different proteins - a total of over 150 combinations. 
THE NICOTINIC ACETYLCHOLINE RECEPTOR (nAChR) 
Although we have found that the in vivo suppression methodology is applicable to a wide variety of 
proteins, here we will focus exclusively on the nAChR.(6) This is the major neuroreceptor at 
neuromuscular junctions, and is increasingly recognized to be important in the brain. It is also present in 
very high concentrations in the electric organs of certain rays and eels, and because of this plentiful source 
the nAChR is the best studied neuroreceptor. The nAChR is the prototypical ligand-gated ion channel, 
being the best studied member of a class that also includes receptors for GABA, glycine, and serotonin. 
The glutamate family of receptors is also related to the nAChR. When agonist (ACh) is released into the 
synapse by the presynaptic neuron, it binds to the nAChR, causing a cation-specific ion channel contained 
within the receptor to open. Nicotine is a competitive agonist of the nAChR, and certainly the neuronal 
nAChRs play an important role in nicotine addiction. 
Structurally, the nAChR is comprised of five subunits arranged in a roughly pentagonal array (Figure 
2).(7) In the muscle form, which will be the focus here, there are four homologous subunits, a, p, y, 6, in a 
ratio a&6. The agonist binding site is thought to be primarily associated with the a subunit, and so there 
are two agonist binding sites that interact in a positively cooperative way (Hill coefficient approaching a 
value of 2). Each subunit is thought to contain a long, extracellular N-terminal region followed by four 
transmembrane regions. The second transmembrane region, M2, is thought to define most of the ion 
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channel, and for several particular residues in M2 there is good evidence that they contribute to the lining 
of the channel. In particular, a highly conserved leucine (Leu) at what is termed the 9’ position of M2 is 
thought to play a critical role in gating the channel.(8,9) If so, then the agonist binding site and the gate to 
the ion channel lie as much as 50 8, apart, making the nAChR a truly remarkable structure. 
Key questions, then, concerning the nAChR include: 
How is the agonist binding site designed to recognize ACh? 
What residues define the ion channel? 
How does binding a small molecule agonist like ACh lead to a conformational change that ultimately 
leads to opening the ion channel? 
THE AGONIST BINDING SITE 
The region thought to define the agonist binding site of the nicotinic receptor was the first to be probed by 
the unnatural amino acid methodology. An especially intriguing feature of this site is the large number of 
aromatic residues (tyrosines and tryptophans) that have been identified by affinity labeling and 
mutagenesis studies (Figure 2).( 10) We proposed some time ago that cation-’ interactions would be 
important in ACh binding sites in general and at the nicotinic receptor in particular.(l 1) 
A 
n 
ion channel (L9’ of M2) 
! 
asubunit 
Fig. 2 Schematics of the nAChR. A. Global layout and dimensions according to the 9A structure of Unwin7. B. 
“Cutaway” view showing the proposed relative positions of the agonist binding sites and the gate of the channel. C. 
Layout of each subunit, using cx as an example. There are 4 transmembrane regions, the second (M2) thought to line 
most of the channel. Note the large number of aromatic residues established to contribute to agonist binding, 
suggesting a role for cation-’ interactions. D. The M2/pore region, emphasizing “rings” of conserved residues. Note 
that many features depicted in A-D are still matters of debate. For example, the positions of the p and 6 subunits 
may be reversed. 
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However, it is clear that all the aromatic amino acids cannot be involved in cation-I interactions - one 
cannot pack eight aromatics around one trimethylammonium ion. We began by studying three highly 
conserved tyrosine residues - a93, 190, and 198 - that had been identified by mutagenesis and labeling 
studies to contribute to the agonist binding site.( 10) It seemed unlikely that all three were playing the same 
role at the receptor, and indeed, studies using conventional mutagenesis had suggested differing roles for 
the three. We felt the unnatural amino acid methodology could better differentiate among the three. 
The unnatural amino acid methodology was especially successful at these sights.(2) We could 
incorporate as many as 16 derivatives of tyrosine and phenylalanine. We report EC,, values - the 
concentration of ACh necessary to achieve half-maximal electrophysiological response. An especially 
interesting trend in the data was seen at the a93 site. As summarized in Figure 3, those sidechains with an 
OH in the 4 position showed EC,, values near, and in some cases even below, that for the wild type 
tyrosine. Those without an OH gave (with one exception - see below) EC,, greater than wild type by at 
least a factor of 7. Conventional mutagenesis studies had shown that complete removal of the OH (a Tyr to 
Phe mutation) raised EC,,,( 1 Ob,c) but one could imagine many reasons for this. However, the unnatural 
amino acid results greatly clarify this observation. An especially telling residue is 4-MeO-Phe. 
Electronically, this substituent is essentially identical to Tyr, but it is in the high EC50 category. Thus, the 
role of the OH of the wild type Tyr is not to alter the electronics of the system. Instead, the results suggest 
that the OH of aTyr93 is involved in a hydrogen bond. The positioning of the OH is important, as 3-OH- 
Phe (“meta-tyrosine”, not shown) is in the high EC,, category. In this light, we interpret the one 
intermediate EC,, value, 4-COOH-Phe, as due to a residue that contains an OH, but one that is not 
optimally positioned. 
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Fig. 3 Selected EC50 values for ACh response for various mutants at a93 of the nAChR. 
Closer inspection, however, reveals an additional aspect of these data. The pK, of the OH of Tyr is ca. 
10, while that for F,-Tyr is ca. 5.3, with the other fluorinated residues having intermediate values.(l2) Yet, 
all give comparable EC,, values. As discussed in detail elsewhere,(2,4) we think the most plausible 
explanation of this observation is that all residues are in the same ionization state, and that state is OH (i.e., 
unionized). Thus, the microenvironment of the agonist binding site is such that an OH with a pK, of 5.3 is 
not ionized. The simplest explanation of this would be a locally hydrophobic environment that elevates 
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pK,. This is certainly precedented in protein chemistry, and is not surprising given the large number of 
aromatic residues at the agonist binding site. An alternative way to suppress ionization of an OH is to have 
it hydrogen-bonded to an ionic group such as a carboxylate. Although no carboxylates on the a subunit 
have ever been implicated in agonist binding, there is a carboxylate on both the y and 6 subunits that does 
influence EC,,.(13) This is consistent with models that place the agonist binding site at the a /y  and a16 
subunit interfaces (Figure 2). Further mutagenesis studies from our labs designed to test for a hydrogen 
bond between aTyr93 and the yl6 carboxylate have not produced conclusive results. 
At a 1  98 no comparably simple pattern is evident in the EC50 data. The 4 substituent seems more a steric 
placeholder, as any substituent comparable in size to an OH seems better than no substituent at all (i.e. 
Phe). Substituents that are too large are deleterious. Certainly, there is no evidence for a hydrogen bond, as 
4-MeO-Phe is the next best residue after the wild type Tyr. 
Position a190 is apparently in a relatively delicate position, as many attempts at unnatural amino acid 
incorporation led to no functional receptors, and those that did work gave universally high EC,, values. 
This is consistent with other studies that suggest a role in both agonist binding and channel gating for this 
site. [ 1 Od] 
None of the data on these Tyr residues are consistent with the operation of a cation-] interaction. This is 
perhaps not surprising, since the cation-’ site in both the acetylcholine esterase(l4) and the 
phosphocholine-binding antibody Fab McPC603( 15) is a tryptophan. Additionally, theoretical studies from 
our labs(l6) show that the indole sidechain of Trp is much better than the phenol of Tyr or the phenyl‘of 
Phe at cation-’ binding. We thus anticipate that one of the several highly conserved Trp residues of the 
agonist binding site will serve as a cation-’ binding site, and studies are underway to identify that residue. 
THE “GATE“ OF THE ION CHANNEL 
A fascinating feature of the nAChR is the highly conserved leucine residue in the M2 region at the position 
identified as 9’ (Figure 2).(8,9) After early studies showed an important role for this residue, a remarkable 
study from the Lester labs(9,17) showed that 9’ Leu to Ser mutations lead to a consistent drop in EC,, 
values by, on average, a factor of 10. To a good approximation, this effect was independent of the subunit 
that contained the mutation, and was additive (in an energetic sense) for multiple Leu-Ser mutations. That 
is, two mutations, regardless of the subunits involved, decreased EC50 by a factor of roughly 100, three 
mutations by a factor of 1000, etc. This suggested that these residues contribute in a symmetrical and 
independent way to the gating. In addition, Unwin’s 9A image of the open receptor suggested a consistent 
model for channel gating.(7) Unwin proposed that in the closed state, these 5 leucine sidechains point in 
toward the channel, forming a “hydrophobic plug”. Channel opening involves conrotatory motion of the 
five M2 units, which are believed to be kinked a helices, thereby swinging the Leu residues away from the 
center and opening the channel. 
The unnatural amino acid methodology provides a powerful tool to evaluate this model. While a Leu to 
Ser mutation certainly alters the hydrophobicity of the 9’ residue, chemists can appreciate that other 
changes are involved also. Sterically, Ser is much different than Leu, and the OH of Ser opens up 
hydrogen bonding possibilities not available to Leu. We thus began a systematic study of this site to 
evaluate the channel gating model. 
Overall, our results (Figure 4) support the importance of hydrophobicity at the 9’ site.(lS) Perhaps most 
convincing are a pair of mutations: isoleucine (Ile) to 0-methylthreonine and do-isoleucine (aIle) to allo- 
0-methylthreonine. In each case a CH, is converted to an ether 0, producing a sidechain with nearly 
identical steric interactions but increased hydrophilicity. For five of six such changes EC,, drops 
substantially, suggesting that increased hydrophobicity at the 9’ site leads to a higher EC,,. A large number 
of other comparisons involving increasing chain lengths to increase hydrophobicity produce consistent 
results. 
Our results also reveal a much more subtle effect that is subunit specific. A comparison of Ile and aIle at 
the 9’ site of the a ,  p, and y subunits shows little difference, and little deviation from the wild type Leu. 
This is not surprising, given the subtle differences amongst the three. Ile and aIle (the latter being an 
unnatural amino acid) differ only in the configuration of the stereocenter in the sidechain, i.e. in the relative 
positions of methyl vs. ethyl groups. However, in the 6 subunit there is a fivefold difference in EC,, values 
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between Ile and aIle (Figure 5 ) ,  with the (also isomeric) wild type Leu showing an intermediate value. We 
interpret this to mean that the 9’ sidechain of the 6 subunit is in a highly structured environment, one that is 
able to distinguish between ethyl and methyl groups. This does not contradict, but rather further refines the 
earlier model. Certainly, something other than just hydrophobicity is involved at the 6 9’ site, as Ile and 
aIle have essentially identical hydrophobicities. Also, there is a subtle asymmetry in the pore region, as this 
stereochemical effect is evident only with the 6 subunit. 
EC50 Values (1M) for 9’ Mutants in [p,y,S] Subunits 
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Fig. 4 Effects of mutations at the 9’ position in M2 of the nAChR. Beneath each sidechain structure are given ACh 
E C g  values for mutations in the p, y, and 6 subunits, in that order. 
To further probe this intriguing structural effect, we acquired single channel recordings using the patch 
clamp technique. The EC,, values we have been reporting come from whole cell (two electrode, voltage 
clamp) measurements. Currents measured arise represent a sum over all the channels on the surface of the 
cell, typicals millions to hundreds of millions of ion channels. Generally, one does not obtain any kinetic 
information from such measurements (although special techniques do exist), and these EC,, values are best 
thought of as thermodynamic data. In contast the remarkable capabilities of the patch clamp methods 
provide different and highly complementary types of data. By isolating a very small number of ion 
channels within the patch and then studying them, one can watch, in real time, the openings and closings of 
individual protein molecules! The time resolution of the technique is adequate to provide valuable kinetic 
information. In the particular measurements reported here (Figure 5 )  we report the mean open time for the 
channels T ~ ~ ~ ~ .  
Gratifyingly, the single channel kinetics qualitatively mirrored the trends in EC,, values (Figure 5). That 
is, channels with lower EC,, values - meaning it takes less ACh to produce measurable whole cell currents 
- show longer T~~~~ values - meaning that once the channel opens, it tends to stay open longer. Note the data 
for the aIle mutant represent the first single channel data on an ion channel containing an unnatural amino 
acid incorporated by the suppression technique, further establishing the broad potential of the 
methodology. It is interesting that substantial variations in channel open times are seen among the leucine 
isomers. This would seem to be inconsistent with a model that emphasizes interactions among 9’ leucines 
in the closed state - the hydrophobic plug model. We will return to this point later. 
We interpret the substantial difference between Ile and aIle to indicate that the 6 9’ substituent is in a 
highly structured environment. In an effort to learn something about what defines that environment, we 
prepared a series of double mutants, combining the now well characterized 9’ Leu to Ser mutation(9,17) in 
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P Y ’  L eu (wild type) 
the other subunits with the series of Leu isomers at the 6 site. In the y subunit (data not shown) the 9’ Leu 
to Ser mutation had no effect on the differences among the Leu isomers. However, a 9’ Leu to Ser mutation 
in the p subunit essentially obliterated the distinction among the 6 9’ Leu isomers (Figure 5 ) .  This result 
carried over to the single channel data - open times for the three Leu isomers in the 6 subunit are 
essentially the same if a p 9’ Leu to Ser mutation is present. 
IJY’ Ser 
b sidechain W O  (PM) 
CH3 
leucine 
5.3 
isoleucine I 
0.80 
‘CH3 I 
allo-isoleucine 
0.8 1.1 
28 
30 
Fig. 5 EC50 values and Topen values for receptors with Leu, Ile, or aIle at the 6 9’ site, and Leu or Ser at the p 9’ 
site. For both EC50 and Topen, the p Leu to Ser mutation eliminates the distinctions among the 6 variants. 
Taken together these observations lead to two important conclusions about the nAChR. First, the data 
indicate a special pair relationship between the p and 6 subunits. We feel the most reasonable interpretation 
of this observation is that the p and 6 subunits are adjacent to each other. Thus, of the two common 
proposals of subunit arrangement around the pore (Figure 6), our data support the arrangement advocated 
most forcefully by Karlin on the basis of agonist binding site studies and recently refined by Hucho (Figure 
6a). The present results constitute the first data fiom the ion channel region that bear on the question of 
subunit arrangement. The model we prefer places the y subunit in the unique position between the two 
nonadjacent a subunits. Thus, y is not adjacent to 6, consistent with the lack of any effect fiom y 9’ Leu to 
Ser mutations on the 6 site. The alternative model advocated by Unwin (Figure 6b) puts p in this unique 
position, and thus 6 adjacent to y. 
A B 0 .*.-.-- rJ..... -... -. 
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Fig. 6 Two possible arrangements of subunits for the nAChR, viewed from the synaptic side. A. The arrangement 
preferred here. B. An alternative arrangement - see text. 
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A second clear implication of our results is that the 9’ sidechains interact strongly in the open state of the 
receptor, at least for the p/S pair. Note that our data do not rule out a substantial interaction in the closed 
state, and in fact detailed analysis of the kinetic data suggest this may well be the case. Still, the finding of 
a strong interaction in the open state does not seem consistent with the model of five inward-pointing Leu 
sidechains forming a hydrophobic plug in the closed state, and then all five M2 helices rotating in the same 
direction to swing the sidechains away from the channel, thus opening it. That is, such a model would seem 
to imply almost no interaction between 9’ sidechains in the open state. 
CONCLUSIONS 
Of course, the nAChR is a complicated, multisubunit protein, and much further work will have to be done 
before a detailed structural and mechanistic model can be developed. But for the present purposes, perhaps 
the more important issue is that we now have the tools to do physical organic chemistry on the central 
molecules of neurobiology. The unnatural amino acid methodology combined with the heterologous 
expression system of the Xenopus oocyte gives us the synthetic tools needed for systematic structural 
modification. The powerful methodologies of electrophysiology provide the necessary analytical tool. 
Whole cell measurements of EC,, values provide a quantitative functional assay for acquiring 
thermodynamic data on the receptor. In addition, the remarkable patch clamp methodologies can produce 
high resolution kinetic data on functioning channels. Finally, as more data become available, the powerful 
methods of computer modeling will increasingly be brought to bear on these remarkable proteins. 
Not just the nAChR but also K’ channels, neurotransmitter transporters, and a wide range of related 
structures are amenable to such high precision studies.(l9) We believe these new tools present a very 
exciting opportunity for physical organic chemists to apply the structural and mechanistic insights 
developed in studies of small molecules to this remarkable class of functioning proteins. 
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